Dassault Systèmes is in talks to acquire a drug trial software company for approximately $2 billion, according to the Financial Times.
FirstSquawk07/17, 01:16 AM
Your privacy choice
S7 Markets works without measurement. If you allow it, we count which screens are opened and which actions are taken, on our own domain and never anything you typed. You can change this in Settings at any time.
Read the privacy policyNews story
FirstSquawk07/17, 01:16 AM